nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A1—head and neck cancer	0.786	1	CbGaD
Toremifene—CYP1A2—Fluorouracil—head and neck cancer	0.0315	0.297	CbGbCtD
Toremifene—ABCB1—Vinblastine—head and neck cancer	0.0255	0.241	CbGbCtD
Toremifene—ABCB1—Docetaxel—head and neck cancer	0.0211	0.199	CbGbCtD
Toremifene—CYP3A4—Vinblastine—head and neck cancer	0.0153	0.144	CbGbCtD
Toremifene—CYP3A4—Docetaxel—head and neck cancer	0.0126	0.119	CbGbCtD
Toremifene—Thromboembolic event—Docetaxel—head and neck cancer	0.00293	0.0432	CcSEcCtD
Toremifene—Foetor hepaticus—Docetaxel—head and neck cancer	0.00139	0.0205	CcSEcCtD
Toremifene—Deep vein thrombosis—Docetaxel—head and neck cancer	0.0013	0.0191	CcSEcCtD
Toremifene—Polyp—Docetaxel—head and neck cancer	0.0013	0.0191	CcSEcCtD
Toremifene—Embolism—Docetaxel—head and neck cancer	0.00123	0.0181	CcSEcCtD
Toremifene—Cyst—Docetaxel—head and neck cancer	0.00118	0.0174	CcSEcCtD
Toremifene—Liver disorder—Docetaxel—head and neck cancer	0.00116	0.0171	CcSEcCtD
Toremifene—Angina pectoris—Vinblastine—head and neck cancer	0.00102	0.015	CcSEcCtD
Toremifene—Breast disorder—Hydroxyurea—head and neck cancer	0.000995	0.0147	CcSEcCtD
Toremifene—Rigors—Docetaxel—head and neck cancer	0.000965	0.0143	CcSEcCtD
Toremifene—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000917	0.0136	CcSEcCtD
Toremifene—Thrombophlebitis—Fluorouracil—head and neck cancer	0.000916	0.0135	CcSEcCtD
Toremifene—Myocardial infarction—Vinblastine—head and neck cancer	0.000912	0.0135	CcSEcCtD
Toremifene—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000912	0.0135	CcSEcCtD
Toremifene—Weight increased—Hydroxyurea—head and neck cancer	0.000866	0.0128	CcSEcCtD
Toremifene—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000832	0.0123	CcSEcCtD
Toremifene—Cardiac failure—Fluorouracil—head and neck cancer	0.000812	0.012	CcSEcCtD
Toremifene—Lethargy—Fluorouracil—head and neck cancer	0.000809	0.0119	CcSEcCtD
Toremifene—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000802	0.0119	CcSEcCtD
Toremifene—Pulmonary embolism—Docetaxel—head and neck cancer	0.000788	0.0116	CcSEcCtD
Toremifene—Hepatocellular injury—Docetaxel—head and neck cancer	0.000788	0.0116	CcSEcCtD
Toremifene—Ataxia—Fluorouracil—head and neck cancer	0.000745	0.011	CcSEcCtD
Toremifene—Alopecia—Vinblastine—head and neck cancer	0.000738	0.0109	CcSEcCtD
Toremifene—Angiopathy—Hydroxyurea—head and neck cancer	0.000691	0.0102	CcSEcCtD
Toremifene—Chills—Hydroxyurea—head and neck cancer	0.000683	0.0101	CcSEcCtD
Toremifene—Alopecia—Hydroxyurea—head and neck cancer	0.000673	0.00995	CcSEcCtD
Toremifene—Angina pectoris—Fluorouracil—head and neck cancer	0.000667	0.00986	CcSEcCtD
Toremifene—Thrombophlebitis—Docetaxel—head and neck cancer	0.000661	0.00976	CcSEcCtD
Toremifene—Vertigo—Vinblastine—head and neck cancer	0.000653	0.00965	CcSEcCtD
Toremifene—Leukopenia—Vinblastine—head and neck cancer	0.000651	0.00962	CcSEcCtD
Toremifene—Hot flush—Docetaxel—head and neck cancer	0.000611	0.00903	CcSEcCtD
Toremifene—Menopausal symptoms—Docetaxel—head and neck cancer	0.000606	0.00896	CcSEcCtD
Toremifene—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000602	0.0089	CcSEcCtD
Toremifene—Myocardial infarction—Fluorouracil—head and neck cancer	0.000599	0.00885	CcSEcCtD
Toremifene—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000599	0.00885	CcSEcCtD
Toremifene—Leukopenia—Hydroxyurea—head and neck cancer	0.000594	0.00877	CcSEcCtD
Toremifene—Cardiac failure—Docetaxel—head and neck cancer	0.000586	0.00866	CcSEcCtD
Toremifene—Lethargy—Docetaxel—head and neck cancer	0.000584	0.00862	CcSEcCtD
Toremifene—Thrombocytopenia—Vinblastine—head and neck cancer	0.000581	0.00858	CcSEcCtD
Toremifene—Anorexia—Vinblastine—head and neck cancer	0.000566	0.00836	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000561	0.00828	CcSEcCtD
Toremifene—Oedema—Hydroxyurea—head and neck cancer	0.000541	0.008	CcSEcCtD
Toremifene—Ataxia—Docetaxel—head and neck cancer	0.000538	0.00795	CcSEcCtD
Toremifene—ESR1—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000537	0.0136	CbGpPWpGaD
Toremifene—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000531	0.00784	CcSEcCtD
Toremifene—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00053	0.00783	CcSEcCtD
Toremifene—Liver function test abnormal—Docetaxel—head and neck cancer	0.000528	0.0078	CcSEcCtD
Toremifene—Skin disorder—Hydroxyurea—head and neck cancer	0.000526	0.00777	CcSEcCtD
Toremifene—Breast disorder—Docetaxel—head and neck cancer	0.000517	0.00764	CcSEcCtD
Toremifene—Anorexia—Hydroxyurea—head and neck cancer	0.000516	0.00762	CcSEcCtD
Toremifene—Decreased appetite—Vinblastine—head and neck cancer	0.000516	0.00762	CcSEcCtD
Toremifene—Constipation—Vinblastine—head and neck cancer	0.000507	0.0075	CcSEcCtD
Toremifene—Pain—Vinblastine—head and neck cancer	0.000507	0.0075	CcSEcCtD
Toremifene—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000507	0.0128	CbGpPWpGaD
Toremifene—Arrhythmia—Fluorouracil—head and neck cancer	0.00049	0.00724	CcSEcCtD
Toremifene—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000489	0.0124	CbGpPWpGaD
Toremifene—Alopecia—Fluorouracil—head and neck cancer	0.000484	0.00716	CcSEcCtD
Toremifene—Dyspnoea—Hydroxyurea—head and neck cancer	0.000482	0.00713	CcSEcCtD
Toremifene—Angina pectoris—Docetaxel—head and neck cancer	0.000482	0.00712	CcSEcCtD
Toremifene—Decreased appetite—Hydroxyurea—head and neck cancer	0.00047	0.00695	CcSEcCtD
Toremifene—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000467	0.0069	CcSEcCtD
Toremifene—Fatigue—Hydroxyurea—head and neck cancer	0.000467	0.00689	CcSEcCtD
Toremifene—Pain—Hydroxyurea—head and neck cancer	0.000463	0.00684	CcSEcCtD
Toremifene—Constipation—Hydroxyurea—head and neck cancer	0.000463	0.00684	CcSEcCtD
Toremifene—ESR1—Estrogen signaling pathway—BCL2—head and neck cancer	0.00046	0.0116	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.000459	0.0116	CbGpPWpGaD
Toremifene—Weight increased—Docetaxel—head and neck cancer	0.00045	0.00665	CcSEcCtD
Toremifene—Vision blurred—Fluorouracil—head and neck cancer	0.00045	0.00665	CcSEcCtD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000443	0.0112	CbGpPWpGaD
Toremifene—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000435	0.00642	CcSEcCtD
Toremifene—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000432	0.00638	CcSEcCtD
Toremifene—Myocardial infarction—Docetaxel—head and neck cancer	0.000432	0.00638	CcSEcCtD
Toremifene—Jaundice—Docetaxel—head and neck cancer	0.00043	0.00635	CcSEcCtD
Toremifene—Leukopenia—Fluorouracil—head and neck cancer	0.000427	0.00631	CcSEcCtD
Toremifene—Asthenia—Vinblastine—head and neck cancer	0.000426	0.00629	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000422	0.0107	CbGpPWpGaD
Toremifene—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000417	0.00616	CcSEcCtD
Toremifene—CYP1A1—Oxidative Stress—SOD2—head and neck cancer	0.000416	0.0105	CbGpPWpGaD
Toremifene—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000415	0.0105	CbGpPWpGaD
Toremifene—Chest pain—Fluorouracil—head and neck cancer	0.000406	0.006	CcSEcCtD
Toremifene—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000398	0.0101	CbGpPWpGaD
Toremifene—CYP1A1—Oxidative Stress—GPX1—head and neck cancer	0.000397	0.0101	CbGpPWpGaD
Toremifene—Dizziness—Vinblastine—head and neck cancer	0.000392	0.0058	CcSEcCtD
Toremifene—Oedema—Fluorouracil—head and neck cancer	0.00039	0.00576	CcSEcCtD
Toremifene—Asthenia—Hydroxyurea—head and neck cancer	0.000388	0.00574	CcSEcCtD
Toremifene—Nervous system disorder—Fluorouracil—head and neck cancer	0.000382	0.00564	CcSEcCtD
Toremifene—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000381	0.00564	CcSEcCtD
Toremifene—Visual impairment—Docetaxel—head and neck cancer	0.000381	0.00563	CcSEcCtD
Toremifene—Vomiting—Vinblastine—head and neck cancer	0.000377	0.00557	CcSEcCtD
Toremifene—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000377	0.00956	CbGpPWpGaD
Toremifene—Headache—Vinblastine—head and neck cancer	0.000372	0.00549	CcSEcCtD
Toremifene—Anorexia—Fluorouracil—head and neck cancer	0.000371	0.00549	CcSEcCtD
Toremifene—Eye disorder—Docetaxel—head and neck cancer	0.00037	0.00546	CcSEcCtD
Toremifene—Angiopathy—Docetaxel—head and neck cancer	0.000359	0.0053	CcSEcCtD
Toremifene—Dizziness—Hydroxyurea—head and neck cancer	0.000358	0.00529	CcSEcCtD
Toremifene—Clomifene—CYP1A1—head and neck cancer	0.000357	0.684	CrCbGaD
Toremifene—Mediastinal disorder—Docetaxel—head and neck cancer	0.000357	0.00527	CcSEcCtD
Toremifene—CYP1A1—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000356	0.00902	CbGpPWpGaD
Toremifene—Chills—Docetaxel—head and neck cancer	0.000355	0.00525	CcSEcCtD
Toremifene—Arrhythmia—Docetaxel—head and neck cancer	0.000354	0.00522	CcSEcCtD
Toremifene—Nausea—Vinblastine—head and neck cancer	0.000352	0.00521	CcSEcCtD
Toremifene—Insomnia—Fluorouracil—head and neck cancer	0.000352	0.00521	CcSEcCtD
Toremifene—Alopecia—Docetaxel—head and neck cancer	0.00035	0.00517	CcSEcCtD
Toremifene—Dyspnoea—Fluorouracil—head and neck cancer	0.000347	0.00513	CcSEcCtD
Toremifene—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000347	0.00879	CbGpPWpGaD
Toremifene—Mental disorder—Docetaxel—head and neck cancer	0.000347	0.00512	CcSEcCtD
Toremifene—Malnutrition—Docetaxel—head and neck cancer	0.000344	0.00509	CcSEcCtD
Toremifene—Vomiting—Hydroxyurea—head and neck cancer	0.000344	0.00508	CcSEcCtD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000342	0.00866	CbGpPWpGaD
Toremifene—Rash—Hydroxyurea—head and neck cancer	0.000341	0.00504	CcSEcCtD
Toremifene—Dermatitis—Hydroxyurea—head and neck cancer	0.000341	0.00504	CcSEcCtD
Toremifene—Headache—Hydroxyurea—head and neck cancer	0.000339	0.00501	CcSEcCtD
Toremifene—Decreased appetite—Fluorouracil—head and neck cancer	0.000339	0.005	CcSEcCtD
Toremifene—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000336	0.00497	CcSEcCtD
Toremifene—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000333	0.00845	CbGpPWpGaD
Toremifene—Back pain—Docetaxel—head and neck cancer	0.000333	0.00492	CcSEcCtD
Toremifene—Pain—Fluorouracil—head and neck cancer	0.000333	0.00492	CcSEcCtD
Toremifene—Nausea—Hydroxyurea—head and neck cancer	0.000321	0.00475	CcSEcCtD
Toremifene—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00032	0.00811	CbGpPWpGaD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—head and neck cancer	0.000312	0.00791	CbGpPWpGaD
Toremifene—ESR1—Estrogen signaling pathway—MAPK1—head and neck cancer	0.00031	0.00784	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—BCL2L1—head and neck cancer	0.000308	0.00781	CbGpPWpGaD
Toremifene—Leukopenia—Docetaxel—head and neck cancer	0.000308	0.00456	CcSEcCtD
Toremifene—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000307	0.00778	CbGpPWpGaD
Toremifene—Chest pain—Docetaxel—head and neck cancer	0.000293	0.00433	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000291	0.0043	CcSEcCtD
Toremifene—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000291	0.00738	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00029	0.00734	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—YAP1—head and neck cancer	0.000288	0.0073	CbGpPWpGaD
Toremifene—Oedema—Docetaxel—head and neck cancer	0.000281	0.00415	CcSEcCtD
Toremifene—Nervous system disorder—Docetaxel—head and neck cancer	0.000276	0.00407	CcSEcCtD
Toremifene—Pruritus—Fluorouracil—head and neck cancer	0.000276	0.00407	CcSEcCtD
Toremifene—Thrombocytopenia—Docetaxel—head and neck cancer	0.000275	0.00407	CcSEcCtD
Toremifene—Skin disorder—Docetaxel—head and neck cancer	0.000273	0.00403	CcSEcCtD
Toremifene—ESR1—Estrogen signaling pathway—PIK3CA—head and neck cancer	0.000269	0.00681	CbGpPWpGaD
Toremifene—Anorexia—Docetaxel—head and neck cancer	0.000268	0.00396	CcSEcCtD
Toremifene—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000268	0.00678	CbGpPWpGaD
Toremifene—CYP1A1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000264	0.00669	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000264	0.00668	CbGpPWpGaD
Toremifene—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000258	0.00653	CbGpPWpGaD
Toremifene—Dizziness—Fluorouracil—head and neck cancer	0.000258	0.00381	CcSEcCtD
Toremifene—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000257	0.00652	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—BCL2L1—head and neck cancer	0.000254	0.00645	CbGpPWpGaD
Toremifene—Insomnia—Docetaxel—head and neck cancer	0.000254	0.00376	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000251	0.00635	CbGpPWpGaD
Toremifene—Dyspnoea—Docetaxel—head and neck cancer	0.000251	0.0037	CcSEcCtD
Toremifene—Vomiting—Fluorouracil—head and neck cancer	0.000248	0.00366	CcSEcCtD
Toremifene—CYP1A1—PPARA activates gene expression—YAP1—head and neck cancer	0.000247	0.00626	CbGpPWpGaD
Toremifene—Rash—Fluorouracil—head and neck cancer	0.000246	0.00363	CcSEcCtD
Toremifene—Dermatitis—Fluorouracil—head and neck cancer	0.000245	0.00363	CcSEcCtD
Toremifene—Decreased appetite—Docetaxel—head and neck cancer	0.000244	0.00361	CcSEcCtD
Toremifene—Headache—Fluorouracil—head and neck cancer	0.000244	0.00361	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—CCND1—head and neck cancer	0.000244	0.00617	CbGpPWpGaD
Toremifene—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000243	0.00359	CcSEcCtD
Toremifene—Fatigue—Docetaxel—head and neck cancer	0.000242	0.00358	CcSEcCtD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	0.000242	0.00613	CbGpPWpGaD
Toremifene—Constipation—Docetaxel—head and neck cancer	0.00024	0.00355	CcSEcCtD
Toremifene—Pain—Docetaxel—head and neck cancer	0.00024	0.00355	CcSEcCtD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00024	0.00608	CbGpPWpGaD
Toremifene—Nausea—Fluorouracil—head and neck cancer	0.000231	0.00342	CcSEcCtD
Toremifene—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000227	0.00575	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000226	0.00574	CbGpPWpGaD
Toremifene—ESR1—Estrogen signaling pathway—AKT1—head and neck cancer	0.000219	0.00556	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—BCL2—head and neck cancer	0.000216	0.00548	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—NAT2—head and neck cancer	0.000208	0.00526	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—NAT2—head and neck cancer	0.000205	0.00519	CbGpPWpGaD
Toremifene—Asthenia—Docetaxel—head and neck cancer	0.000202	0.00298	CcSEcCtD
Toremifene—Pruritus—Docetaxel—head and neck cancer	0.000199	0.00294	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000198	0.005	CbGpPWpGaD
Toremifene—Dizziness—Docetaxel—head and neck cancer	0.000186	0.00275	CcSEcCtD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.000186	0.00471	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—CCND1—head and neck cancer	0.000186	0.0047	CbGpPWpGaD
Toremifene—Vomiting—Docetaxel—head and neck cancer	0.000179	0.00264	CcSEcCtD
Toremifene—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000178	0.00451	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000178	0.00451	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000178	0.00451	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000178	0.0045	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000178	0.0045	CbGpPWpGaD
Toremifene—Rash—Docetaxel—head and neck cancer	0.000177	0.00262	CcSEcCtD
Toremifene—Dermatitis—Docetaxel—head and neck cancer	0.000177	0.00262	CcSEcCtD
Toremifene—Headache—Docetaxel—head and neck cancer	0.000176	0.0026	CcSEcCtD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.000174	0.00441	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—IL2—head and neck cancer	0.00017	0.00431	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.000169	0.00429	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000168	0.00426	CbGpPWpGaD
Toremifene—Nausea—Docetaxel—head and neck cancer	0.000167	0.00247	CcSEcCtD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.000167	0.00422	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000167	0.00422	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL2—head and neck cancer	0.000166	0.00421	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000166	0.00421	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—CCND1—head and neck cancer	0.000166	0.0042	CbGpPWpGaD
Toremifene—Tamoxifen—CYP1A1—head and neck cancer	0.000165	0.316	CrCbGaD
Toremifene—ESR1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000162	0.0041	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—TP53—head and neck cancer	0.000158	0.00399	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.000156	0.00397	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000156	0.00396	CbGpPWpGaD
Toremifene—CYP1A1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000155	0.00394	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000154	0.0039	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—CCND1—head and neck cancer	0.000153	0.00388	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.000153	0.00388	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.000146	0.00369	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000144	0.00365	CbGpPWpGaD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000144	0.00365	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000143	0.00362	CbGpPWpGaD
Toremifene—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000142	0.0036	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00014	0.00354	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.000138	0.0035	CbGpPWpGaD
Toremifene—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000137	0.00348	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—MAPK3—head and neck cancer	0.000137	0.00346	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000132	0.00336	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—STAT3—head and neck cancer	0.000132	0.00335	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—RARB—head and neck cancer	0.000131	0.00332	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000131	0.00332	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000131	0.00331	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—MAPK1—head and neck cancer	0.00013	0.0033	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—EGFR—head and neck cancer	0.00013	0.00329	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000127	0.00322	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—MAPK3—head and neck cancer	0.000126	0.0032	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—MAPK1—head and neck cancer	0.00012	0.00305	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000119	0.00302	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000119	0.00301	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000118	0.00298	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000118	0.00298	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000118	0.00298	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000117	0.00298	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000117	0.00296	CbGpPWpGaD
Toremifene—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000112	0.00283	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000111	0.00282	CbGpPWpGaD
Toremifene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00011	0.00278	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	0.000107	0.0027	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000106	0.00268	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000106	0.00268	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	0.000103	0.0026	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000102	0.00259	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000102	0.00258	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000101	0.00256	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000101	0.00255	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.91e-05	0.00251	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	9.85e-05	0.0025	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	9.82e-05	0.00249	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	9.65e-05	0.00245	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	9.45e-05	0.0024	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	9.22e-05	0.00234	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.01e-05	0.00228	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	8.75e-05	0.00222	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—UROD—head and neck cancer	8.55e-05	0.00217	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	8.52e-05	0.00216	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	8.45e-05	0.00214	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	8.45e-05	0.00214	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	8.41e-05	0.00213	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	8.34e-05	0.00211	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	8.03e-05	0.00203	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	8.01e-05	0.00203	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL2—head and neck cancer	7.98e-05	0.00202	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	7.83e-05	0.00198	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.66e-05	0.00194	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	7.63e-05	0.00193	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	7.62e-05	0.00193	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	7.51e-05	0.0019	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	7.51e-05	0.0019	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	7.51e-05	0.0019	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	7.25e-05	0.00184	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	7.18e-05	0.00182	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	7e-05	0.00177	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	6.87e-05	0.00174	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	6.87e-05	0.00174	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	6.83e-05	0.00173	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—UROD—head and neck cancer	6.83e-05	0.00173	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	6.83e-05	0.00173	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	6.78e-05	0.00172	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.64e-05	0.00168	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	6.54e-05	0.00166	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	6.45e-05	0.00163	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	6.32e-05	0.0016	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RARB—head and neck cancer	6.31e-05	0.0016	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	6.2e-05	0.00157	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	6.12e-05	0.00155	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	6.03e-05	0.00153	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.98e-05	0.00152	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	5.93e-05	0.0015	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	5.77e-05	0.00146	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—YAP1—head and neck cancer	5.74e-05	0.00145	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5.69e-05	0.00144	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5.69e-05	0.00144	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	5.49e-05	0.00139	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—UROD—head and neck cancer	5.45e-05	0.00138	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	5.37e-05	0.00136	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KISS1—head and neck cancer	5.27e-05	0.00134	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	5.21e-05	0.00132	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.05e-05	0.00128	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	5e-05	0.00127	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.98e-05	0.00126	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.94e-05	0.00125	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	4.87e-05	0.00123	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	4.84e-05	0.00123	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.79e-05	0.00121	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.78e-05	0.00121	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.72e-05	0.0012	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.47e-05	0.00113	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GRP—head and neck cancer	4.34e-05	0.0011	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	4.25e-05	0.00108	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.23e-05	0.00107	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT6—head and neck cancer	4.22e-05	0.00107	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—UROD—head and neck cancer	4.21e-05	0.00107	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.04e-05	0.00102	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.84e-05	0.000972	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.77e-05	0.000956	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—YAP1—head and neck cancer	3.73e-05	0.000945	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.7e-05	0.000939	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NAT2—head and neck cancer	3.55e-05	0.0009	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.35e-05	0.000848	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.17e-05	0.000802	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—DPYD—head and neck cancer	3.11e-05	0.000789	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.01e-05	0.000763	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.01e-05	0.000763	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—YAP1—head and neck cancer	2.96e-05	0.000749	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NAT2—head and neck cancer	2.84e-05	0.000719	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.61e-05	0.000662	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH1—head and neck cancer	2.59e-05	0.000655	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.53e-05	0.000641	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—DPYD—head and neck cancer	2.49e-05	0.00063	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.41e-05	0.000609	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.38e-05	0.000603	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—YAP1—head and neck cancer	2.36e-05	0.000598	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NAT2—head and neck cancer	2.26e-05	0.000574	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.22e-05	0.000563	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.13e-05	0.000541	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—DPYD—head and neck cancer	1.99e-05	0.000503	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.94e-05	0.000491	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—YAP1—head and neck cancer	1.88e-05	0.000478	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TYMS—head and neck cancer	1.77e-05	0.00045	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—head and neck cancer	1.75e-05	0.000445	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NAT2—head and neck cancer	1.75e-05	0.000443	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	1.68e-05	0.000426	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPX1—head and neck cancer	1.68e-05	0.000426	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—DPYD—head and neck cancer	1.53e-05	0.000388	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—YAP1—head and neck cancer	1.45e-05	0.000369	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MAPK3—head and neck cancer	1.43e-05	0.000363	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TYMS—head and neck cancer	1.42e-05	0.000359	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.42e-05	0.000359	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—head and neck cancer	1.4e-05	0.000355	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.37e-05	0.000346	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPX1—head and neck cancer	1.34e-05	0.00034	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.33e-05	0.000337	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.23e-05	0.000313	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—head and neck cancer	1.16e-05	0.000293	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TYMS—head and neck cancer	1.13e-05	0.000287	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—head and neck cancer	1.13e-05	0.000286	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.12e-05	0.000283	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTEN—head and neck cancer	1.09e-05	0.000276	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPX1—head and neck cancer	1.07e-05	0.000271	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.06e-05	0.000269	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—head and neck cancer	9.89e-06	0.000251	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—head and neck cancer	9.83e-06	0.000249	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—head and neck cancer	9.74e-06	0.000247	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—head and neck cancer	9.65e-06	0.000245	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK3—head and neck cancer	9.3e-06	0.000236	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK1—head and neck cancer	8.85e-06	0.000224	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGFR—head and neck cancer	8.85e-06	0.000224	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TYMS—head and neck cancer	8.73e-06	0.000221	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.71e-06	0.000221	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—head and neck cancer	8.63e-06	0.000219	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTEN—head and neck cancer	8.63e-06	0.000219	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX1—head and neck cancer	8.27e-06	0.000209	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1A1—head and neck cancer	8.18e-06	0.000207	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—head and neck cancer	7.9e-06	0.0002	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	7.68e-06	0.000195	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—head and neck cancer	7.43e-06	0.000188	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HRAS—head and neck cancer	7.11e-06	0.00018	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTEN—head and neck cancer	6.89e-06	0.000175	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—head and neck cancer	6.31e-06	0.00016	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—head and neck cancer	6.27e-06	0.000159	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—head and neck cancer	6.08e-06	0.000154	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTEN—head and neck cancer	5.5e-06	0.000139	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—head and neck cancer	4.97e-06	0.000126	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.87e-06	0.000123	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—head and neck cancer	4.86e-06	0.000123	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTEN—head and neck cancer	4.24e-06	0.000108	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—head and neck cancer	3.97e-06	0.000101	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.88e-06	9.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—head and neck cancer	3.17e-06	8.03e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.99e-06	7.59e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—head and neck cancer	2.45e-06	6.2e-05	CbGpPWpGaD
